11beta-hydroxysteroid dehydrogenase type 1 inhibitors (Sumitomo Dainippon)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name11beta-hydroxysteroid dehydrogenase type 1 inhibitors (Sumitomo Dainippon)
Drug Alias Name11beta-hydroxysteroid dehydrogenase type 1 inhibitors (Dainippon Sumitomo)DSP-0011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A